Skip to content
DataLookout
Menu

NCT07820046

Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis

StatusRecruiting
PhasePhase 2/3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Primary and study completion moved earlier from Jan 1, 2028 to Jun 1, 2027
    • Start date changed from estimate of Jan 1, 2027 to Oct 25, 2026
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in Mayo Score (Mayo Scoring System for Ulcerative Colitis)
Timeframe: 12 weeks

Arms and interventions

Arm 1Placebo comparator

: Placebo + Standard Therapy Standard ulcerative colitis therapy Placebo tablets twice daily fo

Arm 2:Active comparator

Nitazoxanide + Standard Therapy Nitazoxanide 500 mg orally twice daily Standard ulcerative colitis therapy Duration: 12 weeks

Drugs: Nitazoxanide (NTZ)

Sites

2 sites in 1 country